MannKind Corp. (MNKD)

[COO2002COO]

Danbury area companies to watch in 2015
Dirk Perrefort
Published 9:04 pm, Friday, January 2, 2015


Mannkind

One of several pharmaceutical companies in the Danbury area, Mannkind got a big boost this past year when the company received U.S. Food and Drug Administration approval for its Afrezza, an inhalable form of insulin under development by the company as its main product candidate. Matt Pfeffer, the chief financial officer for the company, said recently that the company initially expects to produce up to 400 million units of the drug, the only inhalable insulin on the market today with FDA approval. The company also expects to hire as many as 100 employees as it ramps up production. Pfeffer said the company could generate close to $4 billion in sales annually out of the Danbury facility. Some analysts, however, have been concerned about the company's selection of Sanofi as its marketing partner for the drug. In November, Sanofi fired its chief executive officer, Chris Viehbache, a big supporter of Afrezza and the company's partnership with Mannkind.


http://www.newstimes.com/business/article/Danbury-area-companies-to-watch-in-2015-5991138.php